| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Charles A. Dinarello | Q834442 |
| P2860 | cites work | Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity | Q68212761 |
| Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor | Q68416701 | ||
| In vitro enhanced thromboxane B2 release by polymorphonuclear leukocytes and macrophages after treatment with human recombinant interleukin 1 | Q68806321 | ||
| Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20) | Q68809097 | ||
| Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis | Q69923865 | ||
| A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets | Q93516981 | ||
| Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor | Q24294731 | ||
| Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein | Q24296266 | ||
| Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor | Q24304040 | ||
| Soluble cytokine receptors are present in normal human urine | Q24681825 | ||
| Protection against pulmonary oxygen toxicity by interleukin-1 and tumor necrosis factor: role of antioxidant enzymes and effect of cyclooxygenase inhibitors | Q28341723 | ||
| Preliminary report: effects of interleukin-1 on platelet counts | Q33386263 | ||
| Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition | Q33449039 | ||
| Interleukin 1 receptor blockade attenuates the host inflammatory response | Q33654500 | ||
| Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist | Q33836551 | ||
| Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins | Q34243621 | ||
| Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist | Q34251859 | ||
| Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis | Q34260899 | ||
| Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s) | Q34544134 | ||
| Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1 | Q34572671 | ||
| Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type | Q35592106 | ||
| Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation | Q36352680 | ||
| Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro | Q37126896 | ||
| Mechanisms of matrix degradation in rheumatoid arthritis | Q37877546 | ||
| Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus | Q38219284 | ||
| Interleukin-1 inhibitors | Q39482871 | ||
| Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1. | Q40764690 | ||
| Monoclonal antibodies reacting with the interleukin 1 receptor define a multi-molecular complex | Q41754142 | ||
| Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/lty/Bcg genes on chromosome 1 | Q42620654 | ||
| A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits | Q43740171 | ||
| Relationship between interleukin 1 (IL1), tumor necrosis factor (TNF) and a neutrophil attracting peptide (NAP-1). | Q43874547 | ||
| Production of interleukin-1-receptor antagonist during experimental endotoxaemia | Q54687598 | ||
| Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice | Q57782997 | ||
| Interleukin-1 receptor antagonist reduces mortality from endotoxin shock | Q59092106 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| immunology | Q101929 | ||
| P304 | page(s) | 941-948 | |
| P577 | publication date | 1991-12-01 | |
| P1433 | published in | Current Opinion in Immunology | Q15752917 |
| P1476 | title | Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases | |
| P478 | volume | 3 |
| Q44448032 | 1H-Imidazo[4,5-c]quinoline derivatives as novel potent TNF-alpha suppressors: synthesis and structure-activity relationship of 1-, 2-and 4-substituted 1H-imidazo[4,5-c]quinolines or 1H-imidazo[4,5-c]pyridines |
| Q71956047 | A common structural motif in immunopotentiating peptides with sequences present in human autoantigens. Elicitation of a response mediated by monocytes and Th1 cells |
| Q42750295 | A possible mechanism for hepatotoxicity induced by BIRB-796, an orally active p38 mitogen-activated protein kinase inhibitor |
| Q24311139 | A protein kinase involved in the regulation of inflammatory cytokine biosynthesis |
| Q40911459 | Adrenomedullin suppresses interleukin-1beta-induced tumor necrosis factor-alpha production in Swiss 3T3 cells |
| Q28210119 | Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro |
| Q28187537 | Aspirin downregulates homocysteine formation in stimulated human peripheral blood mononuclear cells |
| Q90442125 | Benzophenone: a ubiquitous scaffold in medicinal chemistry |
| Q47323104 | Body mass index but not a polymorphism of the interleukin-1 receptor antagonist (IL-1 RA) gene is associated with age at natural menopause |
| Q35886515 | Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation by inflammatory stimuli. |
| Q34102600 | Circulating cytokines as mediators of fever |
| Q43803100 | Cytokine production inhibitors produced by a fungus, Oidiodendron griseum. |
| Q40522276 | Cytokines, inflammation, and autoimmune diseases |
| Q41745119 | Deciphering the apoptotic pathway: all roads lead to death |
| Q31733291 | Development of a p38 Kinase Binding Assay for High Throughput Screening |
| Q73374754 | Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis |
| Q31132977 | Effects of benzalkonium chloride on THP-1 differentiated macrophages in vitro. |
| Q36947591 | Elevation of plasma basic fibroblast growth factor after nocturnal hypoxic events in patients with obstructive sleep apnea syndrome |
| Q50156745 | Endotoxin primes perfused rabbit lungs for enhanced vasoconstrictor response to staphylococcal alpha-toxin |
| Q37195560 | Enhanced angiogenesis, hypoxia and neutrophil recruitment during Myc-induced liver tumorigenesis in zebrafish |
| Q34937361 | Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis |
| Q74455818 | Genetic and immunologic studies of patients on procainamide |
| Q30985468 | Identification of genes induced by inflammatory cytokines in airway epithelium |
| Q36183900 | Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as TNF-α Release Inhibitors by in Silico Explorations |
| Q48183310 | Interleukin 1β polymorphism and serum level are associated with pediatric asthma. |
| Q52592660 | Kinetics of small molecule inhibitor binding to p38 kinase. |
| Q57462089 | Macrophage depletion decreases IgG anti-DNA in cultures from (NZB · NZW)F1 spleen cells by eliminating the main source of IL-6 |
| Q71917533 | Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation |
| Q34996033 | Modulation of virus-induced innate immunity and type 1 diabetes by IL-1 blockade |
| Q27644283 | Molecular basis of MAPK-activated protein kinase 2:p38 assembly |
| Q42264637 | Neutrophil-rich gastric carcinomas: light and electron microscopic study of 9 cases with particular reference to neutrophil apoptosis |
| Q77196472 | Novel cytokine production inhibitors produced by a basidiomycete, Marasmiellus sp |
| Q34522985 | Opposing effects of tumor necrosis factor alpha and leukemia inhibitory factor in lipopolysaccharide-stimulated myelopoiesis |
| Q72119420 | Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor |
| Q35989370 | Proteomic profiling differences in serum from silicosis and chronic bronchitis patients: a comparative analysis |
| Q42537156 | Pyrroles and other heterocycles as inhibitors of p38 kinase |
| Q36791710 | RGD peptide-modified adenovirus expressing hepatocyte growth factor and X-linked inhibitor of apoptosis improves islet transplantation. |
| Q28280225 | S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro |
| Q38283308 | Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered? |
| Q40625851 | Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796) |
| Q42910608 | Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines |
| Q39514484 | Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide. |
| Q39203484 | Synthesis and biological evaluation of asymmetric indole curcumin analogs as potential anti-inflammatory and antioxidant agents. |
| Q43797522 | TNF-alpha and interleukin 1 activate gastrin gene expression via MAPK- and PKC-dependent mechanisms |
| Q45014131 | The combination of rat mast cell and rabbit aortic smooth muscle is the simple bioassay for the screening of anti-allergic ingredient from methanolic extract of Corydalis tuber |
| Q44563645 | The kinetics of binding to p38MAP kinase by analogues of BIRB 796. |
| Q70966187 | Transfer of a mutated gene encoding active transforming growth factor-beta 1 suppresses mitogenesis and IL-1 response in the glomerulus |
| Q57278851 | Tumor Necrosis Factor-α Induces Interleukin-6 Production and Integrin Ligand Expression by Distinct Transduction Pathways |
| Q41622521 | Tumour necrosis factor alpha and interleukin 1 signalling: do MAPKK kinases connect it all? |
| Q38974348 | Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome |
Search more.